Virksomhedsform
Aktieselskab
Etableret
2003
Størrelse
Små
Ansatte
10
Omsætning
349 MDKK
Bruttofortj.
18 MDKK
Primært resultat (EBIT)
8.666.868 DKK
Årets resultat
62 MDKK
Egenkapital
199 MDKK
annonce

Flere nøgletal og analyser?

Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!

Rang Årets resultat

Rang i branche
3/511
"Top 10%"
Rang i Danmark
2.585/356.480
"Top 10%"

Bestyrelse top 3

Steen Meldgaard Astrup 2Bestyrelsesformand
Christoph Schrader 1Bestyrelsesmedlem
Mads Christian Olesen 16Bestyrelsesmedlem

Legale ejere top 3

66.67-89.99%Chr. Olesen A/S
5-9.99%Ignacio de Rojas

Tegningsregler

Selskabet tegnes af en direktør eller et bestyrelsesmedlem eller af den samlede bestyrelse.

Stamoplysninger baseret på CVR

NavnChr. Olesen Nutrition A/S
CVR27270883
AdresseJægersborg Alle 164, 2820 Gentofte
BrancheAnden specialiseret engroshandel i.a.n. [468900]
Etableret30-06-2003 (22 år)
Første regnskabsperiode30-06-2003 til 30-09-2004
VirksomhedsformAktieselskab
Antal ansatte4 (årsværk:3)
ReklamebeskyttelseNej
RevisorPricewaterhousecoopers Statsautoriseret Revisionspartnerselskab siden 01-07-2011
Regnskabsperiode01-10 til 30-09
BankforbindelseSydbank
Selskabskapital537.500 DKK
500.000 DKK (30-06-2003 - 29-09-2022)
Vedtægter seneste30-09-2022

Medlem af brancherne

Formål

Selskabets formål er at drive handel med og distribution af fine chemicals til pharma- og fødevareindustrien.

Regnskab

 202520242023
Valuta/enhed000' DKK000' DKK000' DKK
Omsætning
348.639
-8%
377.029
-34%
569.444
-2%
Bruttofortjeneste
17.652
-27%
24.128
+4%
23.281
-41%
Årets resultat
61.920
+64%
37.692
+23%
30.687
-48%
Egenkapital
199.349
+23%
161.997
+17%
138.779
+8%
Balance
587.447
+29%
456.040
+8%
420.752
-14%

Ledelsesberetning sammendrag

Ledelsesberetning
Key activitiesChr. Olesen Nutrition A/S is part of the Chr. Olesen Group. The company primarily operates as a holding company for the foreign FOOD activities and is maintained through Chr. Olesen A/S’s cost platform.The company operates within international distribution of ingredients and additives for human consumption (FOOD) and is part of the Chr. Olesen Group, which also distributes ingredients for animal feed (FEED), pharmaceutical ingredients (PHARMA) for both humans and animals (ACTIVET), as well as ingredients for the technical industry – including minerals (TECHNICAL INDUSTRIES).Along with the actual trading of the products (buying and selling), Chr. Olesen Group is highly specialized in the service required to be able to deliver the products – i.e. shipping, warehouse management, financing, insurance, bookkeeping and quality management.Development in the yearThe income statement of the Company for 2024/25 shows a profit of EUR 8,288,330, and at 30 September 2025 the balance sheet of the Company shows a positive equity of EUR 26,683,743.The past year and follow-up on development expectations from last yearRevenue for the year is at an expected level. The company has experienced a slight increase compared to what was anticipated.Management is satisfied with the result.The company's intangible key resourcesAs a distributor primarily engaged in the distribution of raw materials, the group does not have intangible resources that need to be reported.That being said, the Chr. Olesen brand, its history, and the long-standing relationships the company has built with both its customers and suppliers are highly valued and protected within the company’s risk management processes.Capital resourcesThe credit facilities of the Chr. Olesen Group are renegotiated every year in January/February. Credit facilities of the same level are expected to be negotiated as last year.Special risks - operating risks and financial risksCurrency risksA significant part of the Group’s transactions take place in foreign currencies. As an element in the Group’s business strategy, the management has determined that day-to-day foreign currency exposures should be hedged by entering into forward exchange contracts, periodical borrowing or placement of funds in foreign currencies.Moreover, currency options are also used for hedging purposes.Targets and expectations for the year aheadFor the coming year, profit before tax is expected to be around EUR 4.5 million and EUR 5.5 million.Subsequent eventsNo events materially affecting the assessment of the Annual Report have occurred after the balance sheet date.Statement on Corporate Social Responsibility – Sustainability ReportingChr. Olesen’s CSR report can be found on Chr. Olesen Group’s website: https://www.chr-olesen.dk/sustainability/
Generalforsamlingsdato: 26-01-2026

Kort